Ciclosporin monitoring: 2-hour post-dose strategy cost saving

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1452, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation

By Paul A. Keown Bryce Kiberd

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Reduction in ciclosporin doses with 2-hour post-dose monitoring

Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cilostazol "likely a cost-saving strategy" following stenting

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cilostazol "likely a cost-saving strategy" following stenting

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 519, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Test-and-treat strategy for latent TB potentially cost saving

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 393, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite